Get started
Author

Justus Bingham

Efficacy and pharmacokinetics of subcutaneous exendin (9‐39) in patients with post‐bariatric hypoglycaemia
2017 · Colleen M. Craig, Li‐fen Liu, et al. · Diabetes Obesity and Metabolism · 48
Reduction of Free Fatty Acids, Safety, and Pharmacokinetics of Oral GS‐9667, an A1 Adenosine Receptor Partial Agonist
2013 · Peter M. Staehr, Arvinder K. Dhalla, et al. · The Journal of Clinical Pharmacology · 27
A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers
2024 · Richard T. Kenney, John K. Cini, et al. · Frontiers in Immunology · 8
A Phase 1, Multicenter, Open Label, Single-Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS) (4484)
2021 · Angela Genge, Maxime Berube-Desrosiers, et al. · Neurology · 6
Absence Of A Clinically Relevant Pharmacokinetic Interaction Between Ambrisentan And Mycophenolate Mofetil
2010 · Arun Mandagere, Bill Coar, et al. · 4
Steady State Tacrolimus Has No Effect On The Steady State Pharmacokinetics Of Ambrisentan In Healthy Subjects
2010 · Arun Mandagere, Bill Coar, et al. · 3
Abstract CT245: Clinical development of a novel form of interleukin-12 with extended pharmacokinetics
2023 · Sant P. Chawla, Victoria S. Chua, et al. · Cancer Research · 1
Pharmacokinetic and pharmacodynamic sub-study of trans-arterial vs. intravenous gemcitabine in the TIGeR-PaC phase 3 clinical trial
2026 · Paula M. Novelli, Emmanuel E. Zervos, et al. · Cancer Chemotherapy and Pharmacology
PDF
Works count: 8
Citation count: 97
H-index: 4
I10-index: 2
Year
Topic
Type